Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)
Taiwan · Delayed Price · Currency is TWD 30.90
-0.05 (-0.16%)
Jan 22, 2026, 1:00 PM CST
Sinphar Pharmaceutical Market Cap
Sinphar Pharmaceutical has a market cap or net worth of 5.88 billion as of January 21, 2026. Its market cap has increased by 10.36% in one year.
Market Cap
5.88B
Enterprise Value
6.81B
Revenue
3.35B
Ranking
n/a
PE Ratio
17.07
Stock Price
30.90
Market Cap Chart
Since April 23, 2003, Sinphar Pharmaceutical's market cap has increased from 1.13B to 5.88B, an increase of 422.22%. That is a compound annual growth rate of 7.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 5.88B | 1.31% |
| Dec 31, 2025 | 5.80B | 2.64% |
| Dec 31, 2024 | 5.65B | -0.75% |
| Dec 29, 2023 | 5.69B | 2.41% |
| Dec 30, 2022 | 5.56B | 14.71% |
| Dec 30, 2021 | 4.85B | -6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 263.50B |
| PharmaEssentia | 217.10B |
| Lotus Pharmaceutical | 88.76B |
| Bora Pharmaceuticals Co., LTD. | 67.84B |
| Heron Neutron Medical | 67.13B |
| Oneness Biotech | 33.73B |
| Center Laboratories | 31.50B |
| Lumosa Therapeutics | 31.25B |